poisar

Stocks · News reference

EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies

BenzingaVandana Singh

Sunshine Biopharma advances its lead coronavirus drug candidate into IND-enabling studies after strong preclinical results in animal models.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading